SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-136219
Filing Date
2024-05-10
Accepted
2024-05-10 16:33:03
Documents
13
Period of Report
2024-05-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A d839106d8ka.htm   iXBRL 8-K/A 57379
  Complete submission text file 0001193125-24-136219.txt   182795

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrus-20240507.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20240507_lab.xml EX-101.LAB 17874
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20240507_pre.xml EX-101.PRE 11216
16 EXTRACTED XBRL INSTANCE DOCUMENT d839106d8ka_htm.xml XML 4421
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37773 | Film No.: 24935497
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)